Detalhe da pesquisa
1.
Factors Associated With Mortality in Patients With Immune-Mediated Rheumatic Diseases and COVID-19 From Latin America: Data From Argentina, Mexico, and Brazil.
J Clin Rheumatol
; 30(1): e9-e17, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37936271
2.
Polar/Golgi-Like Pattern on IIF and Its Association With Rheumatic Diseases.
J Clin Rheumatol
; 27(8S): S420-S422, 2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32195852
3.
An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
Clin Rheumatol
; 41(10): 3199-3209, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35760939
4.
Asociación entre la variación de glóbulos blancos y las manifestaciones clínicas, anticuerpos e infecciones en adultos con lupus eritematoso sistémico / White blood cells count variation in systemic lupus erythematosus: its association to disease manifestations, antibodies and risk of infections
Rev. argent. reumatolg. (En línea)
; 33(3): 136-144, set. 2022. tab, graf
Artigo
em Espanhol
| LILACS, BINACIS | ID: biblio-1423000
5.
Lupus en Argentina. Pacientes no respondedores al tratamiento estándar y belimumab como posible opción. Datos del registro RELESSAR / Lupus in Argentina. Non-responders to standard treatment and belimumab as a possible option. RELESSAR record data
Rev. argent. reumatolg. (En línea)
; 33(1): 14-25, ene. - mar. 2022. tab
Artigo
em Espanhol
| LILACS, BINACIS | ID: biblio-1392898
6.
Lupus en Argentina. Pacientes no respondedores al tratamiento estándar y belimumab como posible opción. Datos del registro RELESSAR / Lupus in Argentina. Non-responders to standard treatment and belimumab as a possible option. RELESSAR record data
Rev. argent. reumatolg. (En línea)
; 33(1): 14-25, ene. - mar. 2022. tab
Artigo
em Espanhol
| LILACS, BINACIS | ID: biblio-1394706